The lasting influence of LSD1 in the blood
An enzyme called LSD1 that controls the development of blood cells by manipulating gene expression in progenitor cells could be a therapeutic target for leukemia.
Main Authors: | Sharon YR Dent, Joya Chandra |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2013-06-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/00963 |
Similar Items
-
Histone demethylase Lsd1 represses hematopoietic stem and progenitor cell signatures during blood cell maturation
by: Marc A Kerenyi, et al.
Published: (2013-06-01) -
LSD1: Expanding Functions in Stem Cells and Differentiation
by: Carlos Martinez-Gamero, et al.
Published: (2021-11-01) -
LSD1/KDM1A, a Gate-Keeper of Cancer Stemness and a Promising Therapeutic Target
by: Panagiotis Karakaidos, et al.
Published: (2019-11-01) -
Expanding the Role of the Histone Lysine-Specific Demethylase LSD1 in Cancer
by: Barbara Majello, et al.
Published: (2019-03-01) -
Histone Modification in NSCLC: Molecular Mechanisms and Therapeutic Targets
by: Khuloud Bajbouj, et al.
Published: (2021-10-01)